A new allergic rhinitis therapy (MP29‐02*) provides effective and rapid symptom relief for patients who suffer most from the bothersome symptoms of nasal congestion or ocular itch
Crossref DOI link: https://doi.org/10.1186/2045-7022-5-S4-P33
Published Online: 2015-06-26
Published Print: 2015-06-26
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Fokkens, Wytske
Hellings, Peter
Mullol, Joaquim
Munzel, Ullrich
Bachert, Claus
Version of Record valid from 2015-06-26
Article History
First Online: 26 June 2015